IE46581B1 - Cromoglycic acid salts and compositions - Google Patents

Cromoglycic acid salts and compositions

Info

Publication number
IE46581B1
IE46581B1 IE530/78A IE53078A IE46581B1 IE 46581 B1 IE46581 B1 IE 46581B1 IE 530/78 A IE530/78 A IE 530/78A IE 53078 A IE53078 A IE 53078A IE 46581 B1 IE46581 B1 IE 46581B1
Authority
IE
Ireland
Prior art keywords
salt
antihistamine
bis
yloxy
propan
Prior art date
Application number
IE530/78A
Other languages
English (en)
Other versions
IE780530L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IE780530L publication Critical patent/IE780530L/xx
Publication of IE46581B1 publication Critical patent/IE46581B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE530/78A 1977-03-17 1978-03-15 Cromoglycic acid salts and compositions IE46581B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11390/77A GB1582362A (en) 1977-03-17 1977-03-17 Cromoglycic acid salts and compositions

Publications (2)

Publication Number Publication Date
IE780530L IE780530L (en) 1978-09-17
IE46581B1 true IE46581B1 (en) 1983-07-27

Family

ID=9985349

Family Applications (1)

Application Number Title Priority Date Filing Date
IE530/78A IE46581B1 (en) 1977-03-17 1978-03-15 Cromoglycic acid salts and compositions

Country Status (18)

Country Link
JP (1) JPS53115823A (enExample)
AU (1) AU516337B2 (enExample)
BE (1) BE864837A (enExample)
CA (1) CA1113862A (enExample)
CH (1) CH628517A5 (enExample)
DE (1) DE2810974A1 (enExample)
DK (1) DK113378A (enExample)
FI (1) FI780782A7 (enExample)
FR (1) FR2383937A1 (enExample)
GB (1) GB1582362A (enExample)
IE (1) IE46581B1 (enExample)
IL (1) IL54264A (enExample)
LU (1) LU79253A1 (enExample)
NL (1) NL7802869A (enExample)
NO (1) NO152297C (enExample)
NZ (1) NZ186712A (enExample)
SE (1) SE444939B (enExample)
ZA (1) ZA781520B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2535258C2 (de) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalierbares Medikament in Pelletform

Also Published As

Publication number Publication date
NL7802869A (nl) 1978-09-19
AU516337B2 (en) 1981-05-28
IL54264A (en) 1984-01-31
GB1582362A (en) 1981-01-07
NO152297C (no) 1985-09-04
NZ186712A (en) 1979-12-11
BE864837A (fr) 1978-09-13
LU79253A1 (fr) 1978-10-17
CH628517A5 (en) 1982-03-15
NO152297B (no) 1985-05-28
IL54264A0 (en) 1978-06-15
JPS53115823A (en) 1978-10-09
NO780935L (no) 1978-09-19
DE2810974A1 (de) 1978-09-21
SE444939B (sv) 1986-05-20
CA1113862A (en) 1981-12-08
DE2810974C2 (enExample) 1988-07-21
FI780782A7 (fi) 1978-09-18
FR2383937B1 (enExample) 1982-07-23
IE780530L (en) 1978-09-17
DK113378A (da) 1978-09-18
AU3427278A (en) 1979-09-20
FR2383937A1 (fr) 1978-10-13
SE7803069L (sv) 1978-09-18
ZA781520B (en) 1979-04-25

Similar Documents

Publication Publication Date Title
AU613107B2 (en) Azelastine-containing medicaments for application in the nose and/or at the eye
US5561149A (en) Use of certain imidazol carbazols in treating stress-related manic-depressive disorders
KR100211479B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제
EP0736022B1 (en) 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
US20020037297A1 (en) Process for the topical treatment of rhinitis, conjunctivitis cold, and cold-like and flu symptoms
CZ283693A3 (en) Antiallergic preparations for use in ophthalmology and otorhinology
US4053628A (en) Composition
US20060228306A1 (en) Combination antihistamine and steroid medication
US3975536A (en) Composition
US4385048A (en) Methods for the treatment of nasal hypersecretion
CA2552458A1 (en) Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
EP1930003A1 (en) Pharmaceutical form containing methocarbamol, meloxicam and betamethasone
CA1113862A (en) Mixtures of 1,3-bis(2-carboxy-chromon-5-yloxy) propan- 2-ol or a salt thereof with an antihistamine having h.sub.1 receptor antagonist properties
CN101491532B (zh) 灯盏细辛酚眼用制剂及其制备方法
EP0577913B1 (en) Ophthalmic composition containing timolol hemihydrate
RU2100020C1 (ru) Средство для местного лечения глазной гипертензии и глаукомы и способ его получения
CA2619863A1 (en) Use of ambroxol for the treatment of rhinovirus infections
HK1007503B (en) Ophthalmic composition containing timolol hemihydrate
CA2083611A1 (en) Use of platelet activating factor antagonists as anti-pruritic agents
CA1131131A (en) Preparation for the treatment of nasal hypersecretion
EP1632229B1 (en) Medicaments for the treatment of urinary tract disorders comprising anticholinergic agents
JP2004026810A (ja) 鼻炎用組成物
AU2022264917A1 (en) Stable isoquinoline-corticosteroid conjugates and uses thereof
WO2007021168A1 (es) Formulaciones farmacéuticas sólidas sublinguales coneniendo meloxicam
MXPA06008935A (en) Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids

Legal Events

Date Code Title Description
MM4A Patent lapsed